Rockefeller Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Buy
61,504
+58,807
+2,180% +$254K ﹤0.01% 2276
2026
Q1
$10.4K Buy
2,697
+1,809
+204% +$7.42K ﹤0.01% 3974
2025
Q4
$3.71K Buy
888
+454
+105% +$1.76K ﹤0.01% 4157
2025
Q3
$1.43K Buy
+434
New +$1.23K ﹤0.01% 4132
2023
Q1
– Sell
-750
Closed -$1K – 3358
2022
Q4
$1K Hold
750
– – ﹤0.01% 3734
2022
Q3
$1K Hold
750
– – ﹤0.01% 3766
2022
Q2
$1K Buy
+750
New +$1.11K ﹤0.01% 3994

Other funds holding PGEN

Rockefeller Capital Management's PGEN Position: Q2 2026 in Review

Rockefeller Capital Management increased its Precigen (PGEN) stake by 2,180% in Q2 2026, buying an estimated $254K and bringing the position to 61,504 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Rockefeller Capital Management first reported a position in PGEN in Q2 2022 and has held it in 7 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Rockefeller Capital Management held 61,504 shares of Precigen worth $351K as of Q2 2026.
  • Rockefeller Capital Management bought 58,807 Precigen shares in Q2 2026, an estimated $254K.
  • Precigen made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2276 holding.
  • Rockefeller Capital Management first reported a position in Precigen in Q2 2022 and has held it in 7 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.